3Q12 worldwide Botox sales in all indications increased 9% YOY in local currencies (+6% in US dollars) to $432M.
Note: Botox sales are seasonal, peaking in the second and fourth calendar quarters, so it’s not worrisome that 3Q12 sales declined by 6% relative to 2Q12.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”